LivaNova PLC announced it has received 510(k) clearance from the FDA for its new Advanced Circulatory Support (ACS) pump and...
Second Sight Medical announced positive three year results post-implant of its Argus II Retinal Prosthesis System from a multi-center clinical...
Saranas, Inc. announced the compelling results of SAFE-MCS, a multi-center clinical study evaluating the safety of complex high-risk percutaneous coronary intervention (PCI) using mechanical circulatory support (MCS) and surveillance with the Early Bird Bleed Monitoring System (EBBMS)
CurveBeam received FDA 510(k) marketing clearance for its LineUP multi-extremity weight bearing CT system. The system allows radiologists and orthopedic...
Teleflex Incorporated announced the publication of positive results from a multi-center study reaffirming the safety and effectiveness of the minimally...
The FDA has issued an approval letter for the MelaFind Lesion Imaging System Pre-Market Approval application. MelaFind, from MELA Sciences,...
CathWorks announced that its FFRangio System received FDA 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive FFR wire...
For the symptomatic relief of upper respiratory tract disorders which are benefited by a combination of a nasal decongestant and histamine H 1 -receptor antagonist, for example: Allergic Rhinitis Vasomotor Rhinitis The Common Cold and Influenza
Trevena, Inc. announced that TRV 027, the Company’s novel AT1 receptor selective agonist, has been selected for inclusion in an international, multi-site, adaptive, Phase II-Phase III trial in COVID-19 patients .
Doctors involved in a multi-centre clinical study for the treatment of Post-Stroke Shoulder Pain have made the first implantation of...